[Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia].

What does this source report?

Cortagen and Cortexin accelerated recovery of disturbed behavior and reduced oxidative-stress changes.

Population and setting

Rats with experimental chronic brain ischemia

Evidence type

Animal / experimental

Preparation

See the original report; formulation details require verification.

Source language

English indexed abstract; original language:

Title provenance

Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

• Chronic experimental ischemia is not an acute-stroke trial or evidence of human benefit.
• Full methods, reporting completeness and independent replication remain to be appraised.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Review depth: Abstract reviewed

Source access and review scope

Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.

Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.

Source provenance: Original journal report

Open original source or index record ↗

Cite and trace this record

Original source: Zarubina IV, Shabanov PD. [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]. Eksperimental'naia i klinicheskaia farmakologiia · PMID 21476278 2011.

Molekul research summary: https://molekul.io/research/audit-21476278. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Related compound profiles